0000914190-15-000294.txt : 20150811
0000914190-15-000294.hdr.sgml : 20150811
20150811163940
ACCESSION NUMBER: 0000914190-15-000294
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150807
FILED AS OF DATE: 20150811
DATE AS OF CHANGE: 20150811
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eansor Norman David
CENTRAL INDEX KEY: 0001270905
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 151044384
MAIL ADDRESS:
STREET 1: 8100 SOUTHPARK WAY, A-8
CITY: LITTLETON
STATE: CO
ZIP: 80120
FORMER NAME:
FORMER CONFORMED NAME: EANSOR N DAVID
DATE OF NAME CHANGE: 20031120
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-08-07
0000842023
BIO-TECHNE Corp
TECH
0001270905
Eansor Norman David
8100 SOUTHPARK WAY, A-8
LITTLETON
CO
80120
0
1
0
0
SVP - Novus Biologicals
Common Stock
4469
D
Stock Option (Right to Buy)
94.35
2021-08-12
Common Stock
15000
15000
D
Stock Option (Right to Buy)
108.49
2015-08-07
4
A
0
12500
0
A
2022-08-07
Common Stock
12500
12500
D
Stock Option (Right to Buy)
108.49
2015-08-07
4
A
0
6250
0
A
2022-08-07
Common Stock
6250
6250
D
Restricted Stock Units
2015-08-07
4
A
0
1000
0
A
Common Stock
1000
1000
D
Includes 3,333 shares of restricted stock units that vest 1,667 shares on 7/1/16 and 1,666 shares on 7/1/17 (previously reported on Table II).
3,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.
3,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years.
/s/ Elizabeth M. Dunshee as Attorney-in-Fact for David N. Eansor pursuant to Power of Attorney previously filed.
2015-08-11